Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Biopharma Trends & CDMOs | Contract Pharma

What are you searching for?

Sign in
Videos

Biopharma Trends & CDMOs

Steve King of iBio discusses biopharma trends impacting CDMOs and the opportunities they present

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Earlier in June, iBio introduced its cGMP sterile fill-finish capabilities for pharmaceutical products, including monoclonal antibodies, viral vectors and other biologics at its 135,000 square foot CDMO facility in Bryan, TX. iBio recently initiated its new operation with the signing of a supply agreement with a clinical-stage biopharmaceutical company developing gene and cell therapies. 

Under the supply agreement, iBio will formulate and fill clinical research quantities of one of the customer’s investigational therapies into sterile vials for use in a planned late-stage clinical trial.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics